Free Trial

Fulgent Genetics (FLGT) Competitors

$20.95
+0.29 (+1.40%)
(As of 07/12/2024 ET)

FLGT vs. CSTL, BDSX, GTH, PSNL, AHCO, INNV, GRAL, VSEE, OPCH, and FTRE

Should you be buying Fulgent Genetics stock or one of its competitors? The main competitors of Fulgent Genetics include Castle Biosciences (CSTL), Biodesix (BDSX), Genetron (GTH), Personalis (PSNL), AdaptHealth (AHCO), InnovAge (INNV), Grail (GRAL), Vsee Health (VSEE), Option Care Health (OPCH), and Fortrea (FTRE).

Fulgent Genetics vs.

Castle Biosciences (NASDAQ:CSTL) and Fulgent Genetics (NASDAQ:FLGT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, community ranking, earnings and dividends.

92.6% of Castle Biosciences shares are owned by institutional investors. Comparatively, 48.1% of Fulgent Genetics shares are owned by institutional investors. 7.2% of Castle Biosciences shares are owned by insiders. Comparatively, 31.8% of Fulgent Genetics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Castle Biosciences presently has a consensus target price of $31.00, suggesting a potential upside of 67.12%. Fulgent Genetics has a consensus target price of $30.00, suggesting a potential upside of 43.20%. Given Fulgent Genetics' stronger consensus rating and higher probable upside, research analysts plainly believe Castle Biosciences is more favorable than Fulgent Genetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Castle Biosciences
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Fulgent Genetics
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Castle Biosciences has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500. Comparatively, Fulgent Genetics has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500.

In the previous week, Castle Biosciences had 2 more articles in the media than Fulgent Genetics. MarketBeat recorded 3 mentions for Castle Biosciences and 1 mentions for Fulgent Genetics. Castle Biosciences' average media sentiment score of 1.87 beat Fulgent Genetics' score of 0.95 indicating that Fulgent Genetics is being referred to more favorably in the news media.

Company Overall Sentiment
Castle Biosciences Positive
Fulgent Genetics Very Positive

Castle Biosciences has higher earnings, but lower revenue than Fulgent Genetics. Castle Biosciences is trading at a lower price-to-earnings ratio than Fulgent Genetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Castle Biosciences$219.79M2.33-$57.47M-$1.15-16.13
Fulgent Genetics$289.21M2.17-$167.82M-$5.57-3.76

Castle Biosciences has a net margin of -12.28% compared to Castle Biosciences' net margin of -57.72%. Castle Biosciences' return on equity of -2.92% beat Fulgent Genetics' return on equity.

Company Net Margins Return on Equity Return on Assets
Castle Biosciences-12.28% -7.91% -6.95%
Fulgent Genetics -57.72%-2.92%-2.70%

Fulgent Genetics received 162 more outperform votes than Castle Biosciences when rated by MarketBeat users. However, 62.60% of users gave Castle Biosciences an outperform vote while only 60.70% of users gave Fulgent Genetics an outperform vote.

CompanyUnderperformOutperform
Castle BiosciencesOutperform Votes
82
62.60%
Underperform Votes
49
37.40%
Fulgent GeneticsOutperform Votes
244
60.70%
Underperform Votes
158
39.30%

Summary

Castle Biosciences beats Fulgent Genetics on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FLGT vs. The Competition

MetricFulgent GeneticsMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$626.91M$2.27B$5.40B$8.72B
Dividend YieldN/A2.00%2.78%4.04%
P/E Ratio-3.7619.19126.3218.29
Price / Sales2.17129.422,179.4084.35
Price / Cash6.45337.4936.4533.15
Price / Book0.554.184.944.46
Net Income-$167.82M-$128.23M$111.49M$215.59M
7 Day Performance6.78%7.21%6.20%5.35%
1 Month Performance9.74%4.21%5.71%4.39%
1 Year Performance-45.95%-9.66%6.55%1.77%

Fulgent Genetics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CSTL
Castle Biosciences
1.5203 of 5 stars
1.52 / 5 stars
$18.55
+0.3%
$31.00
+67.1%
+14.5%$510.46M$219.79M-16.13610News Coverage
Gap Up
BDSX
Biodesix
2.5026 of 5 stars
2.50 / 5 stars
$1.69
+1.8%
$3.10
+83.4%
+45.7%$190.38M$49.09M-3.07217Short Interest ↑
News Coverage
GTH
Genetron
0 of 5 stars
0.00 / 5 stars
$4.03
+0.2%
N/A+49.3%$127.43M$94.34M0.00993High Trading Volume
PSNL
Personalis
4.3617 of 5 stars
4.36 / 5 stars
$1.66
-2.4%
$5.00
+201.2%
-24.2%$88.30M$73.48M-0.87223Gap Up
AHCO
AdaptHealth
1.257 of 5 stars
1.26 / 5 stars
$10.61
+1.3%
$10.70
+0.8%
-17.2%$1.39B$3.20B-2.0110,700Short Interest ↑
INNV
InnovAge
0.2788 of 5 stars
0.28 / 5 stars
$5.70
+6.3%
$6.50
+14.0%
N/A$728.89M$688.09M-23.752,100Positive News
GRAL
Grail
0 of 5 stars
0.00 / 5 stars
$14.81
+1.6%
N/AN/A$452.44MN/A0.001,360Positive News
VSEE
Vsee Health
0 of 5 stars
0.00 / 5 stars
$6.48
-1.7%
N/AN/A$0.00N/A0.00N/APositive News
Gap Down
High Trading Volume
OPCH
Option Care Health
4.6113 of 5 stars
4.61 / 5 stars
$29.37
+1.4%
$40.00
+36.2%
-6.4%$5.03B$4.30B19.327,802Gap Up
FTRE
Fortrea
2.4139 of 5 stars
2.41 / 5 stars
$26.00
+5.1%
$32.30
+24.2%
N/A$2.21B$3.11B-18.7118,000Positive News

Related Companies and Tools

This page (NASDAQ:FLGT) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners